| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |